Curevo Vaccine
Drug DiscoveryWebsite
Developer of a clinical-stage adjuvanted subunit vaccine intended to improve efficacy and broaden immune response. The company leverages its proprietary platform to design and develop vaccines that ta...
Valuation
$0
Share Price
N/A
Total Raised
$206.2M
Last Round
Later Stage VC (Series B)
Mar 2025
Latest Funding Round
Later Stage VC (Series B)
Mar 6, 2025
$110M
raised
Investors
+12 other investors